Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)
This study has been completed.
Study NCT00067093   Information provided by Sanofi-Aventis
First Received: August 11, 2003   Last Updated: April 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Deep Vein Thrombosis
Additional conditions recognized in this trial
Thrombosis
Venous Thrombosis
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Vascular Diseases
Interventions listed in this trial
SanOrg34006
LMW heparin
Unfractionated heparin
Vitamin K antagonist (VKA)
Additional drug interventions recognized in this trial
Heparin
Heparin, Low-Molecular-Weight
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services